Atorvastatin Calcium Tablet, Film Coated
NDC Package 0904-6291-06
Package Information
Atorvastatin Calcium tablets are indicated: •To reduce the risk of: oMyocardial infarction (MI), stroke, revascularization procedures, and angina in adults with multiple risk factors for coronary heart disease (CHD) but without clinically evident CHDoMI and stroke in adults with type 2 diabetes mellitus with multiple risk factors for CHD but without clinically evident CHDoNon-fatal MI, fatal and non-fatal stroke, revascularization procedures, hospitalization for congestive heart failure, and angina in adults with clinically evident CHD•As an adjunct to diet to reduce low-density lipoprotein cholesterol (LDL-C) in: oAdults with primary hyperlipidemia.oAdults and pediatric patients aged 10 years and older with heterozygous familial hypercholesterolemia (HeFH).•As an adjunct to other LDL-C-lowering therapies, or alone if such treatments are unavailable, to reduce LDL-C in adults and pediatric patients aged 10 years and older with homozygous familial hypercholesterolemia (HoFH).• As an adjunct to diet for the treatment of adults with:oPrimary dysbetalipoproteinemiaoHypertriglyceridemia. This formulation utilizes a tablet, film coated delivery system. Marketed by Major Pharmaceuticals, this product is identified by NDC 0904-6291 and is authorized under FDA application ANDA090548.
Identification & Billing
- RxCUI: 617310 - atorvastatin calcium 20 MG Oral Tablet
- RxCUI: 617310 - atorvastatin 20 MG Oral Tablet
- RxCUI: 617310 - atorvastatin (as atorvastatin calcium) 20 MG Oral Tablet
- RxCUI: 617312 - atorvastatin calcium 10 MG Oral Tablet
- RxCUI: 617312 - atorvastatin 10 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0904 - Major Pharmaceuticals
- 0904-6291 - Atorvastatin Calcium
- 0904-6291-06 - 50 BLISTER PACK in 1 CARTON / 1 TABLET, FILM COATED in 1 BLISTER PACK
- 0904-6291 - Atorvastatin Calcium
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (0904-6291). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0904-6291-06 identifies a specific commercial package of 50 blister pack in 1 carton / 1 tablet, film coated in 1 blister pack of Atorvastatin Calcium, a human prescription drug labeled by Major Pharmaceuticals. This tablet, film coated is formulated for oral use and contains atorvastatin calcium propylene glycol solvate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Major Pharmaceuticals on May 29, 2012. The current certification is valid through December 31, 2027.
How is this Major Pharmaceuticals product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00904629106. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 50 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.